Gepotidacin
- Generic Name
- Gepotidacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H28N6O3
- CAS Number
- 1075236-89-3
- Unique Ingredient Identifier
- DVF0PR037D
- Background
Gepotidacin has been used in trials studying the treatment of Gonorrhea, Infections, Bacterial, and Infections, Respiratory Tract.
- Associated Conditions
- -
- Associated Therapies
- -
Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
- First Posted Date
- 2018-06-19
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 25
- Registration Number
- NCT03562117
- Locations
- 🇺🇸
GSK Investigational Site, Orlando, Florida, United States
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 32
- Registration Number
- NCT02729038
- Locations
- 🇺🇸
GSK Investigational Site, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath